Our people-centric design innovation is recognised on the global awards stage
An AstraZeneca concept collaboration is one of three projects by deep tech consultants at Cambridge Consultants to receive prestigious iF DESIGN AWARDS
Generative biology breakthrough from Capgemini – PharmaTimes
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes
Capgemini reveals gen AI-driven breakthrough to accelerate the bioeconomy
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development.
Omniscia：リアルタイムでの超人的な手術
ディープラーニングとAI強化画像処理による超人的な手術はOmnisciaを推進し、リアルタイムビデオ超解像の標準を定めます。
What is deep tech? A strategy to create value from an enduring, defensible competitive advantage
What is deep tech? When discussing deep tech meaning, deep tech consultants Cambridge Consultants define it as a strategy for value and commercial advantage.
緑内障による失明との闘いにおける有望なブレイクスルー
緑内障とは何でしょうか？それは世界中で不可逆な失明の主な原因となる症状です。ケンブリッジコンサルタンツ科学者とエンジニアのチームが、緑内障の主な要因である眼圧（IOP）のモニタリングに関する有望なブレイクスルーを達成しました。